The Clorox Company (NYSE:CLX) Stock Position Increased by Somerset Trust Co

Somerset Trust Co boosted its position in shares of The Clorox Company (NYSE:CLX) by 5.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,214 shares of the company’s stock after buying an additional 723 shares during the quarter. Somerset Trust Co’s holdings in Clorox were worth $2,308,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of CLX. Prospera Private Wealth LLC bought a new position in shares of Clorox in the third quarter valued at $27,000. Continuum Advisory LLC grew its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP lifted its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the 3rd quarter valued at $48,000. Finally, Friedenthal Financial purchased a new position in Clorox in the 3rd quarter worth about $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE CLX opened at $160.31 on Friday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The business’s 50-day moving average price is $164.35 and its two-hundred day moving average price is $156.20. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a market capitalization of $19.84 billion, a P/E ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.49 earnings per share. Analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is presently 170.04%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Barclays lowered their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Finally, StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and an average price target of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.